3Tasaka K.Epinastine:An update of its pharmacology,metabolism,clinical efficacy and tolerability in the treatment of allergic diseases[J].Drugs Today(Barc),2000,36(11):735-757. 被引量：1
4Grant JA,Riethuisen JM,Moulaert B,et al.A double-blin randomized,single-dose,crossover comparison of levocetirizine with ebastine,fexofenadine,loratadine,mizolastine,and placebo:suppression of histamine-induced wheal-and-flare response during 24 hours in healthy male subjects[J].Ann Allergy Asthma Immunol,2002,88(2):190-197. 被引量：1
2Tasaka K.Epinastine:An update of its pharmacology,metabolism,clinical efficacy and tolerability in the treatment of allergic diseases.Drugs Today (Barc),2000,36:735-757. 被引量：1
3Grant JA,Danielson L,Rihoux JP,et al.A double-blind,single-dose,crossover comparison of cetirizine,ebastine,epinastine,fexofenadine,terfenadine,and loratadine versus placebo:suppression of histamine-induced wheal and flare response for 24 h in healthy male subjects.Allergy,1999,54:700-707. 被引量：1
